Rojas, Katerin
Baliu-Piqué, Mariona
Manzano, Aránzazu
Saiz-Ladera, Cristina
García-Barberán, Vanesa
Cimas, Francisco J.
Pérez-Segura, Pedro
Pandiella, Atanasio
Győrffy, Balázs
Ocana, Alberto http://orcid.org/0000-0002-1067-9630
Funding for this research was provided by:
Instituto de Salud Carlos III (PI19/00808)
ACEPAIN
CIBERONC
CRIS Cancer Foundation
Instituto de Salud Carlos III (RD12/0036/0003)
Ministerio de Economía y Competitividad (BFU2015-71371-R)
AECC
CRIS Cancer Foundation
CIBERONC
National Research, Development and Innovation Office, Hungary (NVKP_16-1-2016-0037)
National Research, Development and Innovation Office, Hungary (2018-1.3.1-VKE-2018-00032)
National Research, Development and Innovation Office, Hungary (KH-129581)
Article History
Received: 1 July 2020
Revised: 9 December 2020
Accepted: 11 December 2020
First Online: 19 January 2021
Compliance with ethical standards
:
: A.O. receives funding from Entrechem, travel expenses from Merck and advisory board fees from Daiichi Sankyo. P.P.S. receives funding from Merck and MSD. A.P. receives consultancy fees from Daiichi Sankyo.
: This study does not involve human participants or experimental animal models.
: This manuscript does not contain personal and/or medical information on identifiable living individuals.